An update on implantable cardioverter-defibrillator guidelines

Current Opinion in Cardiology

Volumn 19, Issue 1, 2004, Pages 23-25

  Epstein, Andrew E ^a  

^a University of Alabama at Birmingham and Birmingham Veterans Affairs Medical Center   (United States)

Author keywords

Cardiac arrest; Implantable cardioverter defibrillator; Sudden death

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

BRUGADA SYNDROME; CLINICAL TRIAL; CONGESTIVE CARDIOMYOPATHY; CORONARY ARTERY DISEASE; DEFIBRILLATOR; HEART DISEASE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE REVASCULARIZATION; HEART RIGHT BUNDLE BRANCH BLOCK; HEART VENTRICLE TACHYCARDIA; HIGH RISK PATIENT; HOSPITAL ADMISSION; HUMAN; INTERMETHOD COMPARISON; MORTALITY; PRIORITY JOURNAL; QRS COMPLEX; REVIEW; SINUS NODE; ST SEGMENT ELEVATION; STATISTICAL SIGNIFICANCE; SUDDEN DEATH; SYNCOPE; ARTIFICIAL HEART PACEMAKER; CARDIOLOGY; CLASSIFICATION; CONGESTIVE HEART FAILURE; LEGAL ASPECT; PHYSIOLOGY; PRACTICE GUIDELINE; STANDARD;

CARDIOLOGY; DEFIBRILLATORS, IMPLANTABLE; HEART FAILURE, CONGESTIVE; HUMANS; PACEMAKER, ARTIFICIAL; PRACTICE GUIDELINES; TACHYCARDIA, VENTRICULAR; VENTRICULAR FUNCTION, LEFT;

EID: 2442701017     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001573-200401000-00006     Document Type: Review

References (14)

1. Gregoratos G, Cheitlin MD, Conill A, et al. ACC/AHA guidelines for implantation of cardiac pacemakers and antiarrhythmia devices: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Pacemaker Implantation). Circulation 1998; 97:1325-1335. J Am Coll Cardiol 1998; 31:1175-1206. This document was the guideline that forms the basis of the current update.
2. Gregoratos G, Cheitlin MD, Conill A, et al. ACC/AHA guidelines for implantation of cardiac pacemakers and antiarrhythmia devices: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Pacemaker Implantation). Circulation 1998; 97:1325-1335. J Am Coll Cardiol 1998; 31:1175-1206. This document was the guideline that forms the basis of the current update.
3. Gregoratos G, Abrams J, Epstein AE, et al. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to update the 1998 pacemaker guidelines). Circulation 2002:106:2145-2161; J Am Coll Cardiol 2002;40:1703-1719. J Cardiovasc Electrophysiol 2002;13:1181-1199. www.acc.org/clinical/guidelines/pacemaker/pacemaker/pdf. This document was the guideline that forms the basis of the current update.
4. Gregoratos G, Abrams J, Epstein AE, et al. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to update the 1998 pacemaker guidelines). Circulation 2002:106:2145-2161; J Am Coll Cardiol 2002;40:1703-1719. J Cardiovasc Electrophysiol 2002;13:1181-1199. www.acc.org/clinical/guidelines/pacemaker/pacemaker/pdf. This document was the guideline that forms the basis of the current update.
5. Gregoratos G, Abrams J, Epstein AE, et al. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to update the 1998 pacemaker guidelines). Circulation 2002:106:2145-2161; J Am Coll Cardiol 2002;40:1703-1719. J Cardiovasc Electrophysiol 2002;13:1181-1199. www.acc.org/clinical/guidelines/pacemaker/pacemaker/pdf. This document was the guideline that forms the basis of the current update.
6. Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduce ejection fraction. N Engl J Med 2002; 346:877-883. Landmark study showing utility of prophylactic ICDs in patients with coronary heart disease, poor ventricular function, and no arrhythmia marker.
7. The DAVID Trial Investigators (writing committee: Wilkoff BL, Cook JR, Epstein AE, et al.). Dual chamber pacing or ventricular backup pacing for patients with an implantable defibrillator. JAMA 2002; 288:3115-3123. Important study showing that right ventricular pacing in patients without an indication for pacing but an indication for ICD implantation have worse outcomes than those who are not paced.
8. Abildstrom SZ, Torp-Pedersen C, Kober L. Implication of MADIT-II on unselected patients following an acute myocardial infarction. J Am Coll Cardiol 2003, 41(suppl):96A.
9. Daubert JP, Zareba W, Schuger CD, et al. Does EPS inducibility in MADIT II predict subsequent VT and/or VF events? PACE 2003; 26:960.
10. Nademanee K, Veerakul G, Mower M, et al. Defibrillator versus β-blockers for unexplained death in Thailand (DEBUT): a randomized clinical trial. Circulation 2003; 107:2221-2226.
11. Knight BP, Goyal R, Pelosi R, et al. Outcome of patients with nonischemic dilated cardiomyopathy and unexplained syncope treated with an implantable defibrillator. J Am Coll Cardiol 1999; 33:1964-1970.
12. Young JB, Abraham WT, Smith AL, et al. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure. The MIRACLE ICD Trial. JAMA 2003; 289:2685-2694. Landmark study showing utility of combined cardiac resynchronization therapy and ICD therapy in patients with advanced CHF.
13. Bardy GH, Lee KL, Mark DB, et al. Sudden cardiac death in heart failure trial: pilot study. PACE 1997; 20:1148.
14. Kadish A, Quigg R, Schaechter A, et al. Defibrillators in nonischemic cardiomyopathy treatment evaluation. PACE 2000; 23:338-343.